Skip to main content
. 2022 Jun 7;12:9373. doi: 10.1038/s41598-022-13465-x

Table 1.

Baseline characteristics of patients.

Patients
(N = 372)
Age (years) mean (SD), range 79.4 (8.9), 53–102
Sex (female), n (%) 283 (76.1)
Type of fracture, n (%)
Pertrochanteric 191 (51.3)
Intracapsular 151 (40.6)
Subtrochanteric 24 (6.4)
Others 6 (1.6)
Identification of patients, n (%)
Emergency registry 217 (58.3)
Admission 129 (34.6)
Rheumatology osteoporosis clinic 26 (6.9)
Previous treatment with bisphosphonates, n (%)a 53 (14.4)
Risk factors for fracture, n (%)
Previous fragility fracture 76 (20.4)
Parental hip fracture 35 (9.4)
Smoking 37 (9.9)
Corticosteroids 40 (10.7)
Rheumatoid arthritis 10 (2.7)
Secondary osteoporosis 59 (15.8)
Alcohol 17 (4.6)
Densitometry results, n (%)a
Normal 11 (5.3)
Osteopenia 81 (39.1)
Osteoporosis 115 (55.5)
T score lumbar spine, mean (SD) − 1.9 (1.6)
T score femoral neck, mean (SD) − 2.4 (1.0)
FRAX
FRAX major, mean (SD) 18.4 (10.2)
FRAX hip, mean (SD) 9.7 (8.2)
Referral after baseline visit, n (%)a
Rheumatology osteoporosis clinic 57 (15.3)
Primary care 315 (84.7)

aPrevious treatment recorded in 369 patients. Densitometry values were recorded in 207 patients.